Insulin-Like Growth Factor Binding Protein 4 (IGFBP4) Peptide
IGFBP4
Reactivité: Humain, Boeuf (Vache), Souris
Hôte: Synthetic
BP, Imm
-
- Antigène Tous les produits IGFBP4
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Origine
- Humain, Boeuf (Vache), Souris
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Séquence
- KGELDCHQLA DSFRE
- Attributs du produit
- The peptide was used in the production of ABIN370208 - Goat Anti-IGFBP4 Antibody. It is currently untested in blocking applications.
-
-
- Indications d'application
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Stock
- -20 °C
- Stockage commentaire
- Shipped at ambient temperature, store at -20°C.
-
- Antigène
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Synonymes
- IGFBP4 Peptide, igfbp4 Peptide, BP-4 Peptide, HT29-IGFBP Peptide, IBP4 Peptide, IGFBP-4 Peptide, AI875747 Peptide, Deb2 Peptide, IGF-BP4 Peptide, IBP-4 Peptide, insulin like growth factor binding protein 4 Peptide, insulin-like growth factor-binding protein 4 Peptide, insulin-like growth factor binding protein 4 Peptide, IGFBP4 Peptide, LOC100136305 Peptide, LOC100194498 Peptide, igfbp4 Peptide, Igfbp4 Peptide
-
Vous êtes ici:
